DuPont to launch cholesterol-controlling probiotic range

Tuesday, 03 June, 2014

DuPont Nutrition and Health has signed a global collaboration and licensing agreement with Spanish company AB-Biotics for its AB-Life product, a probiotic that maintains healthy levels of cholesterol in at-risk individuals.

Under the terms of the agreement, DuPont will have exclusive rights for the production, marketing and sales of AB-Life and AB-Biotics will continue to conduct clinical research on the health benefits of AB-Life.

DuPont is integrating AB-Life into its HOWARU probiotic range for the dietary supplement and food and beverage industries. The company says it will launch the product in Q4 2014.

The product will add to DuPont’s portfolio for cardiovascular health, which includes Danisco Pinvita phytosterols and Danisco Evesse EPC, a natural apple extract and soy protein.

“We are excited to work with AB-Biotics to support probiotics for heart health,” said Fabienne Saadane-Oaks, vice president Health and Protection, DuPont Nutrition & Health.

“Probiotics is a fast-growing segment of our business as people increasingly experience the benefits they can provide. Our HOWARU formulations have been clinically tested and shown to deliver the digestive and immune support people need, and we are looking forward to adding cardiovascular support to our probiotics portfolio.”

Related News

Clean-label functional ingredients of the future

Australia's Food and Beverage Accelerator has invested in SeaStock Pty Ltd to accelerate the...

Arla Foods Ingredients concept for protein bar innovation

Making its debut at SupplySide Global is a concept created by Arla Foods Ingredients to...

Call for comment on GM enzyme processing aid

FSANZ is calling for comment on an application to permit the use of phosphoinositide...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd